These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program. Vohra V; Stroh-Steiner GK; Jones P Clin Toxicol (Phila); 2023 Dec; 61(12):1040-1046. PubMed ID: 38088581 [TBL] [Abstract][Full Text] [Related]
3. Signals of increasing co-use of stimulants and opioids from online drug forum data. Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501 [TBL] [Abstract][Full Text] [Related]
4. Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department. Ali SA; Shell J; Harris R; Bedder M Harm Reduct J; 2023 Oct; 20(1):144. PubMed ID: 37798673 [TBL] [Abstract][Full Text] [Related]
5. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic. Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589 [TBL] [Abstract][Full Text] [Related]
6. The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015. Walley AY; Bernson D; Larochelle MR; Green TC; Young L; Land T Public Health Rep; 2019; 134(6):667-674. PubMed ID: 31577519 [TBL] [Abstract][Full Text] [Related]
7. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018. Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642 [No Abstract] [Full Text] [Related]
8. Treatment of opioid overdose: current approaches and recent advances. Britch SC; Walsh SL Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972 [TBL] [Abstract][Full Text] [Related]
9. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids. Roxburgh A; Hall WD; Gisev N; Degenhardt L Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378 [TBL] [Abstract][Full Text] [Related]
10. Unintentional overdoses: understanding the fentanyl landscape and reducing harm. Bell LA; Hadland SE Curr Opin Pediatr; 2023 Aug; 35(4):408-414. PubMed ID: 36974444 [TBL] [Abstract][Full Text] [Related]
11. Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone. Kline A; Williams JM; Steinberg ML; Mattern D; Chesin M; Borys S; Chaguturu V J Subst Use Addict Treat; 2023 Jun; 149():209028. PubMed ID: 37003539 [TBL] [Abstract][Full Text] [Related]
12. Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis. Wightman RS; Perrone J; Scagos R; Krieger M; Nelson LS; Marshall BDL J Med Toxicol; 2021 Jan; 17(1):10-15. PubMed ID: 32648229 [TBL] [Abstract][Full Text] [Related]
13. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018. Lee B; Zhao W; Yang KC; Ahn YY; Perry BL JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816 [TBL] [Abstract][Full Text] [Related]
14. Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality. Laing R; Donnelly CA PLoS One; 2024; 19(7):e0306395. PubMed ID: 38980856 [TBL] [Abstract][Full Text] [Related]
16. Treatment of overdose in the synthetic opioid era. Skolnick P Pharmacol Ther; 2022 May; 233():108019. PubMed ID: 34637841 [TBL] [Abstract][Full Text] [Related]
17. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings. Perrone J; Haroz R; D'Orazio J; Gianotti G; Love J; Salzman M; Lowenstein M; Thakrar A; Klipp S; Rae L; Reed MK; Sisco E; Wightman R; Nelson LS Ann Emerg Med; 2024 Jul; 84(1):20-28. PubMed ID: 38493376 [TBL] [Abstract][Full Text] [Related]
18. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders. Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213 [TBL] [Abstract][Full Text] [Related]
19. Evidence of Pre-mortem Opioid Use among Fentanyl Overdose Decedents in a Safety Net Healthcare System. Coffin PO; McMahan VM; Murphy C J Urban Health; 2022 Oct; 99(5):865-872. PubMed ID: 35879486 [TBL] [Abstract][Full Text] [Related]